Home

Catalyst Healthcare
Consulting

Igniting progress at the intersection of regulation, policy,
and innovation

Advancing the
bottom line with
the patient in mind

Catalyst Healthcare Consulting is a dynamic, hands-on regulatory policy and regulatory affairs partner dedicated to helping clients advance innovative healthcare solutions that benefit patients.

Our team builds fit-for-purpose solutions to accelerate product development, advance policy objectives, improve the regulatory environment, understand reimbursement realities, all to help inform business decisions.  Our clients include global innovators, start-ups, state agencies, patient advocates, investors, universities, non-profits and trade associations.

Our core team

With you at every stage of development

At Catalyst, we prefer the cutting edge. Our creativity is unleashed as we work with clients across a mix of projects that support start-ups, global sponsors, patient groups, and emerging coalitions of like-minded innovators.

Our broad-reaching portfolio gives us a 360° view of the healthcare ecosystem. By thinking like patients, industry leaders, investors, and regulators, we anticipate trends and craft bold solutions to complex challenges.

Discover how Catalyst’s expertise can power your success.

Start-up support

Advancing products
and pipelines

Building industry
consensus

View capabilities

20 years of advancing partner objectives

Catalyst’s strength is the diversity and complexity of the projects we choose to accept, both at home and abroad

Our clients include

  • Industry: cell and gene therapy, pharma,
digital therapeutics, and devices
  • Trade associations
  • Patient advocacy organizations
  • Venture capital and investment firms
  • Law and public relations firms
  • State agencies
  • Academic institutions
See expanded list

Upcoming events

BioFuture 2025 Annual Conference

October 13-15

Nancy Myers will be speaking at BioFuture’s 2025 annual conference, held in New York City, this October. If you are attending, we would love to meet you!

FDA CBER OTP Public Listening Meeting: Leveraging Knowledge for Facilitating the Development and Review of Cell and Gene Therapies.

September 18th

Nancy Myers will be presenting at OTP’s upcoming public listening meeting on C&G Therapies this September. 

Learn more